**Specifications table**TableSubject areaClinical ChemistryMore Specific subject areaMass spectrometry and steroid measurementType of dataGraph, table and chromatogramHow data was acquiredLC-MS/MS and chemiluminescencent immunoassayData formatRaw and processed dataExperimental factorsFor LC-MS/MS analysis a serum sample was extracted with organic solvent. The organic extract was dried, reconstituted and injected into the LC/MS-MS system for analysis [@bib1]. For immunoassay analysis human serum was placed onto the analyzer according to the manufacturer׳s guidelines [@bib2], [@bib3].Experimental featuresSpecimens analyzed by LC-MS/MS for estradiol and testosterone were compared with a chemiluminescencent immunoassays. Structurally related and/or isobaric compounds of estradiol and testosterone were evaluated for baseline separation. Various calibration materials were tested and compared with international reference standards.Data source locationNew York, NY, United StatesData accessibilityData are available with this article

**Value of data**•The data shows a comparison of testosterone by LC-MS/MS with a readily available chemiluminescencent immunoassay at concentrations spanning the analytical measurement range.•The data shows a comparison of estradiol by LC-MS/MS with a readily available chemiluminescencent immunoassay at concentrations spanning the analytical measurement range.•The data shows baseline separation of estradiol and testosterone from potentially interfering structurally related and/or isobaric compounds.

1. Data {#s0005}
=======

The following data, [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, show the correlation between the LC-MS/MS assay and the chemiluminescencent immunoassay for estradiol and testosterone. [Fig. 3](#f0015){ref-type="fig"} shows baseline separation of estradiol and testosterone from potentially interfering structurally related and/or isobaric compounds. [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"} show a comparison of calibration materials with international reference materials for estradiol and testosterone.Fig. 1(A) Correlation between the newly developed HPLC-MS/MS assay and the Architect i2000 immunoassay for testosterone; (B) Correlation between the newly developed HPLC-MS/MS assay and the Architect i2000 immunoassay at the low end of the analytical measurement range.Fig. 1Fig. 2(C) Correlation between the newly developed HPLC-MS/MS assay and the Architect i2000 immunoassay for estradiol; (D) Correlation between the newly developed HPLC-MS/MS assay and the Architect i2000 immunoassay at the low end of the analytical measurement range.Fig. 2Fig. 3(A) A positive ion chromatogram showing baseline separation of isobaric and structurally related compounds that have the potential to interfere with estradiol and testosterone. (B) A negative ion chromatogram showing baseline separation of isobaric and structurally related compounds that have the potential to interfere with estradiol and testosterone.Fig. 3Fig. 4Comparison of various calibrator materials to the European Commission Institute for Reference Materials and Measurements (IRMM) certified reference material (BCR 576, 577, and 578) for estradiol in human serum.Fig. 4Fig. 5Comparison of various calibrator materials to the National Institute of Standards & Technology (NIST) standard reference material (SRM 971F and SRM 971M) for testosterone in human serum.Fig. 5

2. Experimental design, materials and method {#s0010}
============================================

2.1. Method comparison {#s0015}
----------------------

The LC-MS/MS assay used to obtain the data set is given in [@bib1]. The immunoassay used for testosterone is the Abbott Architect 2nd Generation Assay (Chicago, IL, USA). The assay is a chemiluminescencent micro particle immunoassay for the quantitive determination of testosterone in human serum or plasma. This assay releases testosterone from binding proteins and measures the total testosterone level. This assay was performed according the manufacturer׳s guidelines [@bib2]. The estradiol assay was from Abbott Diagnostic and was also a chemiluminescencent immunoassay used for the quantitive determination of estradiol in human serum or plasma. This assay was performed according the manufacturer׳s guidelines [@bib3].

2.2. Chromatographic separation {#s0020}
-------------------------------

The LC-MS/MS parameters used in this study are given [@bib1]. In order to rule out interference from structurally related and/or isobaric compounds, Chromsystems level III quality control from their MassCheck^®^ Steroid Panel 1 [@bib4] and Panel 2 [@bib5] were combined. The analytes in this mixture were optimized for peak identification to ensure baseline separation from estradiol and testosterone.

2.3. Calibrator comparison with international reference material {#s0025}
----------------------------------------------------------------

For estradiol, certified reference material BCR 576, 577, and 578 was from the European Commission Institute for Reference Materials and Measurements (Geel, Belgium). For testosterone, standard reference materials SRM 971F and 971M were from the National Institute of Standards & Technology (Gaithersburg, MD, USA). Estradiol and testosterone were obtained from Sigma-Aldrich (Saint-Louis, MO, USA) and the calibrators were prepared gravimetrically. The commercially available Abbott Diagnostics (Chicago, IL, USA) and Chromsystems (Grafelfing, Germany) calibrators were prepared according to the manufacture׳s instructions [@bib2], [@bib3], [@bib6].

Funding sources {#s0030}
===============

This work was supported by the Department of Laboratory Medicine of Memorial Sloan Kettering Cancer Center and through the NIH/NCI Cancer Center Support Grant P30 CA008748.

Transparency document. Supplementary material {#s0040}
=============================================

Supplementary material.

Transparency data associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.08.077>.
